An interventional study of Banana and No banana in Type 1 Diabetes, sponsored by University of Aarhus. Not yet recruiting. Open to participants aged 15 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-04-08.
Sponsored by University of Aarhus · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus — 6 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 1 · University of Aarhus.
Among the 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus, this one is the 9th largest by planned enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 20th registered.
3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.
Browse Diabetes Mellitus, Type 1 studies →6 of the 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus are open now, in 1 country. Recruiting first, the newest first:
University of Aarhus · Sites in Denmark
Ages 40+
University of Aarhus · Sites in Denmark
Ages 20–70 · Healthy volunteers
University of Aarhus · Sites in Denmark
Ages 18+
University of Aarhus · Sites in Denmark
Ages 18–65 · Healthy volunteers
University of Aarhus
Ages 18+
By country, each count listing its studies:
Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.
This study: 15 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 40 across 2,824 interventional studies indexed under Diabetes Mellitus, Type 1.
Median enrollment 20 across the 21 interventional studies, 12 across the 3 observational. Of the 18 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Aarhus is the lead sponsor of 1,303 studies on the registry; 190 are open to participants now.
1 of the studies in Diabetes Mellitus, Type 1 by University of Aarhus that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07172672University of AarhusThe TiMeD-T1D Project | 2027-02-01 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Diabetes Mellitus, Type 1 by University of Aarhus, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Former and current KADET athletes participate in two controlled training sessions: one with a banana 20 minutes pre-exercise and one without. Tandem Data recorded includes sensor glucose, training details, insulin dosing, and meal intake. Continuous glucose monitoring (CGM) data is assessed. Endpoints include differences in glucose levels, hypoglycemia events (SG \<3.9 mmol/L), and Time in Range during training
Participants:
Former and current KADET athletes invited via a Facebook group. Previous participants in study projects who have expressed interest in being contacted for future studies.
Protocol:
Participants provide written consent for data collection and use.
Each participant completes two training sessions under controlled conditions, including:
Same training time Standardized pre-training meal timing and insulin corrections Similar intensity and environmental factors If pre-training hypoglycemia occurs, training is rescheduled or corrected with glucose tablets, which are documented.
Study Conditions:
Session 1: Participant eats a banana 20 minutes before training. Session 2: No pre-training food intake.
Tandem Control IQ users (insulin pump) take a microbolus (0.05 IE) before banana intake.
Recorded Data by participant:
Training start and end times Sensor glucose (SG) at start and end of training Training type and intensity (Borg scale, heart rate monitoring) Last insulin dose (meal and correction) Last meal details (content and timing) Banana documentation (photo, weight with peel, ripeness level)
CGM data are also assessed.
Endpoints:
Differences in GCG glucose level Time to hypoglycemia and number of hypoglycemia events (SG \<3.9 mmol/L) on banana vs. non-banana days.
Percentage of Time in Range during training. Additional data is reported as available.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No banana consumed prior exercise
Other: No banana
Banana consumed 20 minutes prior exercise
Dietary Supplement: Banana
A banana is consumed pre-exercise in order to prevent hypoglycemia
No banana is consumed pre-exercise
CGM glucose
CGM glucose Time in Range between 3.9 and 10 mmol/l
Time frame: approximately 60 minute monitoring period during exercise
Time to hypoglycemia
minutes to hypoglycemia after exercise has begun
Time frame: approximately 30 to 30 minutes
Borg scale
Level of excaution evaluated on Borg scale from 6-20
Time frame: Borg scale is assessed approximately 15 minutes after exercise
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2025; primary completion for Nov 2025, 7 months later.
Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 7 months is below that.
Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Banana